JamesMartinezMD

PubMed

• 4 citations
  Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment.
  Miguel J. A. Láinez, Jean Schoenen, Chad Stroud, Jennifer N. Bardos, Mark E. Bangs, Phebe Kemmer, Richard Wenzel, Dulanji K. Kuruppu, James M. Martinez, Tina M. Oakes> ;Headache. 2021 Nov 22
• 2 citations
  Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Hea...
  J. Scott Andrews, David Kudrow, Mallikarjuna Rettiganti, Tina M. Oakes, Jennifer N. Bardos, Richard Wenzel, Dulanji K. Kuruppu, Charly Gaul, James M. Martinez> ;Journal of Pain Research. 2021 Jul 8
• 4 citations
  Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache
  David Kudrow, J. Scott Andrews, Mallikarjuna Rettiganti, Tina M. Oakes, Jennifer N. Bardos, Charly Gaul, Robert Riesenberg, Richard Wenzel, Dulanji K. Kuruppu, James M...> ;Headache. 2020 Nov 1
• 6 citations
  Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine
  James M. Martinez, Nada Hindiyeh, Greg Anglin, Kavita Kalidas, Michael E Hodsdon, William Kielbasa, Brian A. Moser, Eric M. Pearlman, Sandra Garces> ;Cephalalgia. 2020 Apr 27
• 56 citations
  Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment.
  David W. Dodick, Peter J. Goadsby, Christian Lucas, Rigmor Jensen, Jennifer N. Bardos, James M. Martinez, Chunmei Zhou, Sheena K. Aurora, Jyun Yan Yang, Robert R. Conl...> ;Cephalalgia. 2020 Feb 12
• 108 citations
  Trial of Galcanezumab in Prevention of Episodic Cluster Headache.
  Peter J. Goadsby, David W. Dodick, Massimo Leone, Jennifer N. Bardos, Tina M. Oakes, Brian A. Millen, Chunmei Zhou, Sherie A. Dowsett, Sheena K. Aurora, Andrew H. Ahn,...> ;The New England Journal of Medicine. 2019 Jul 10
• 15 citations
  Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis
  Peter J. Goadsby, David W. Dodick, James M. Martinez, Margaret B. Ferguson, Tina M. Oakes, Qi Zhang, Vladimir Skljarevski, Sheena K. Aurora> ;Journal of Neurology, Neurosurgery, and Psychiatry. 2019 Apr 19
• 16 citations
  Societal burden of cluster headache in the United States: a descriptive economic analysis.
  Janet H. Ford, Damion Nero, Gilwan Kim, Bong Chul Chu, Robert Fowler, Jonna Ahl, James M. Martinez> ;Journal of Medical Economics. 2018 Jan 1
• 105 citations
  Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial
  Vladimir Skljarevski, Tina M. Oakes, Qi Zhang, Margaret B. Ferguson, James M. Martinez, A. Camporeale, Kirk W. Johnson, Qiuling Shan, Jeffrey N. Carter, Aaron Leigh Sc...> ;JAMA Neurology. 2017 Dec 18
• 18 citations
  Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data.
  Casey Choong, Janet H. Ford, Allen W. Nyhuis, Shivang Joshi, Rebecca L. Robinson, Sheena K. Aurora, James M. Martinez> ;Headache. 2017 Oct 1
• 1 citations
  Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder.
  James M. Martinez, Margaret B. Ferguson, Beth A. Pangallo, Tina M. Oakes, JonDavid Sparks, Mary Anne Dellva, Qi Zhang, Peng Liu, Mark E. Bangs, Jonna Ahl, Celine Goldb...> ;Drugs in Context. 2015 May 13
• 7 citations
  Treatment and outcomes for patients with depression who are partial responders to SSRI treatment: post-hoc analysis findings from the FINDER European observational study.
  A Lenox-Smith, James M. Martinez, David G.S. Perahia, Sherie A. Dowsett, Ellen B. Dennehy, P Lopez-Romero, Koen Demyttenaere> ;Journal of Affective Disorders. 2014 Dec 1
• 20 citations
  Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*D.
  M Ferguson, Ellen B. Dennehy, Lauren B. Marangell, James M. Martinez, Stephen R. Wisniewski> ;Current Medical Research and Opinion. 2014 Jun 20
• 18 citations
  Clinical and functional outcomes of patients who experience partial response to citalopram: secondary analysis of STAR*D.
  Ellen B Dennehy, Lauren B. Marangell, James M. Martinez, Goundappa K. Balasubramani, Stephen R. Wisniewski> ;Journal of Psychiatric Practice. 2014 May 1
• 11 citations
  The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-market...
  David G.S. Perahia, Mark E. Bangs, Qi Zhang, Yingkai Cheng, Jonna Ahl, Elijah P Frakes, Michael J Adams, James M. Martinez> ;Drug, Healthcare and Patient Safety. 2013 Nov 25
• 7 citations
  Evaluation of genetic models for response in a randomized clinical trial of duloxetine in major depressive disorder
  John P. Houston, Wei Zou, Virginie Aris, Bonnie Fijal, Peining Chen, Alexandra N. Heinloth, James M. Martinez> ;Psychiatry Research. 2012 Nov 30
• 5 citations
  Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen:...
  Vladimir Skljarevski, Peng Liu, Shuyu Zhang, Jonna Ahl, James M. Martinez> ;Pain Research and Treatment. 2012 Mar 18
• 24 citations
  A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-sever...
  James M. Martinez, Wayne Katon, John H. Greist, Kurt Kroenke, Michael E. Thase, Adam L. Meyers, Sara E. Edwards, Lauren B. Marangell, Scarlett Shoemaker, Ralph Swindle> ;International Clinical Psychopharmacology. 2012 Jan 1
• 25 citations
  Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.
  Paula J. Gaynor, Murali Gopal, Wei Zheng, James M. Martinez, Michael J. Robinson, Danette Hann, Lauren B. Marangell> ;Current Medical Research and Opinion. 2011 Sep 21
• 33 citations
  A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
  Paula J. Gaynor, Murali Gopal, Wei Zheng, James M. Martinez, Michael J. Robinson, Lauren B. Marangell> ;Current Medical Research and Opinion. 2011 Sep 21
• 20 citations
  The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study.
  Maurizio Fava, James M. Martinez, John H. Greist, Lauren B. Marangell, Eileen Brown, Lei Chen, Madelaine M. Wohlreich> ;Annals of Clinical Psychiatry. 2007 Jul 1
• 22 citations
  An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
  Madelaine M. Wohlreich, James M. Martinez, Craig H. Mallinckrodt, Apurva Prakash, John G. Watkin, Maurizio Fava> ;Journal of Clinical Psychopharmacology. 2005 Dec 1
• Join now to see all